Pregnancy studies are increasingly based on health care databases due to their relative ease of access, large sample size and relative low cost compared to ad hoc data collection. Accurate ascertainment of pre-existing health conditions during pregnancy is vital for the validity of these studies.
misclassification in database studies. However, administrative databases pose unique challenges for disease ascertainment as well, as chronic conditions are often under-recorded 2 and this recording may also be differential with respect to outcomes of interest.
The approaches to deal with misclassification of pre-existing conditions depend on the type of database. In longitudinal databases (eg, administrative claims), a natural strategy to capture most conditions is to ascertain them during a long interval. However, this approach reduces sample size because only individuals enrolled for the entire duration of the interval are eligible. In most pregnancy studies, the ascertainment interval is typically the pregnancy period. 3, 4 In cross-sectional databases (eg, Nationwide Inpatient Sample), researchers are restricted to ascertaining both the pre-existing conditions and the outcome of interest in the same medical encounter. [6] [7] [8] This is problematic because the presence of obstetric complications may affect the recording of pre-existing conditions.
We used administrative claims to (1) assess the relative recording accuracy of pre-existing epilepsy and multiple sclerosis (MS)
at the delivery hospitalization and in a longer pregnancy interval, both overall and by commonly associated major obstetric outcomes (Caesarean delivery, preterm delivery and preeclampsia) 6,7,9,10 and (2) compare risk ratios for the association between the pre-existing conditions and these obstetric outcomes when the ascertainment window of the pre-existing conditions varies. We restricted the cohort to women continuously enrolled with prescription claim data for at least 270 days before the delivery until, and including, the delivery date (Information on how the 270-day interval length was chosen is provided in Appendix S1). Continuous enrollment was defined as evidence of enrollment in a health insurance plan for at least 28 days in each month in the study period. From this cohort we compared women with the pre-existing conditions identified in the full 270 days before and including the date of delivery ('pre-delivery interval') to women with the pre-existing conditions identified at the delivery hospitalization ('delivery interval'; Median length of delivery hospitalization was 2 days).
| ME THODS

| Study population
To simulate studies from longitudinal and cross-sectional data, we based definitions of the conditions on definitions commonly used in the literature for each ascertainment interval. 6, 7, [12] [13] [14] [15] [16] In the pre-delivery interval, a strict definition was used to maximize the specificity. MS was defined as the ICD-9-CM code 340.xx on two separate days and epilepsy was defined as any of the ICD-9-CM codes 345.0x-345.5x, 345.7x-345.9x, 649.4x, on two separate days plus at least one prescription claim for the antiepileptic medications (Table S1 ). In the delivery hospitalization interval, MS and epilepsy were both defined as at least one ICD-9-CM code for their respective conditions. We described maternal characteristics in women with epilepsy, women with MS, and women without either of these conditions as defined in the pre-delivery interval using the codes listed in Appendix S2.
| Measurements of agreement
We calculated the proportion of women with the condition recorded at the delivery hospitalization, among those classified with the preexisting condition in the pre-delivery interval ("Relative Sensitivity").
We also calculated the proportion of women classified with the preexisting condition in the pre-delivery interval, among those with the condition recorded at the delivery hospitalization ("Relative Predictive Value").
We presented these measurements overall and stratified by three obstetric outcomes ascertained in the maternal record during (3) Preeclampsia (ICD-9-CM: 642.4x-642.7x).
| Impact on measures of association
We calculated the risk ratios for the three obstetric outcomes when the pre-existing conditions were defined i) during the pre-delivery interval and ii) at delivery hospitalization. Risk ratios were estimated using generalized linear models with a log link, Poisson distribution, and robust variances. All models were adjusted for maternal age, region, and year of delivery. Heterogeneity of risk ratios from each ascertainment interval was tested using the Cochrane Q test and P-values were reported. Statistical analyses were conducted using SAS Enterprise Guide version 6.1 (SAS Institute Inc.). 
| RE SULTS
| Measurements of agreement
Among those meeting the criteria for epilepsy in the pre-delivery interval, 73% were also recorded as having epilepsy at delivery (Relative Sensitivity). For MS, the Relative Sensitivity was 60%. Among those with epilepsy recorded at delivery, 63% also met the definition for epilepsy in the pre-delivery interval (Relative Predictive Value). For MS, the Relative Predictive Value was 78%. The Relative Predictive Value of epilepsy was lower among those experiencing preterm delivery (56% vs 64%), or preeclampsia (47% vs 65%) than among those without the obstetric outcomes.
As women with preeclampsia are also more likely to have a preterm delivery, 17 we re-calculated the Relative Predictive Value for the remaining outcomes in a cohort excluding those with preeclampsia to determine if low values exist for all preterm deliveries or just those with co-occuring preeclampsia. After this exclusion, the Relative Predictive Value increased for those with preterm delivery (Appendix S4).
In contrast with epilepsy, the Relative Predictive Values for MS recorded at delivery were similar or greater in those with the obstetric outcomes as compared with those without them. Figure 2 presents the risk ratios for the obstetric outcomes when the pre-existing condition was ascertained in the pre-delivery interval and at the delivery hospitalization. Epilepsy defined in the pre-delivery interval was associated with an increased risk of 03 [95% CI 0.78, 1.35] ). MS at delivery was similarly associated with Caesarean delivery (P-value for heterogeneity: .53), preterm delivery (P-value for heterogeneity: .37), and preeclampsia (P-value for heterogeneity: .24). Analyses with varying pre-delivery definitions of both epilepsy and MS found overall similar patterns as the primary analyses (Appendix S5).
| Impact of misclassification on measures of association
| COMMENT
| Principal findings
The prevalences of epilepsy and MS were under-estimated when ascertainment occurred during the delivery hospitalization as compared with the pre-delivery interval. This misclassification generally appeared non-differential by major obstetric outcomes and most measures of association did not vary by the ascertainment window.
| Interpretation
For epilepsy, 73% of women with the condition in the pre-delivery interval were also recorded as having epilepsy at delivery. Recording was lower in those delivering preterm than in those delivering at term, suggesting that more complicated deliveries may distract from the recording of chronic conditions in the insurance claims. Only 63%
of those recorded at delivery met the stricter condition definition in the pre-delivery interval. This proportion was 47% in women with preeclampsia, which may be explained by (1) neurologic symptoms associated with preeclampsia, including eclamptic seizures, being incorrectly recorded using epilepsy codes, or (2) more complete documentation of distant seizure disorders in women with preeclampsia (less likely because the Relative Sensitivities were virtually equivalent in those with and without preeclampsia). Regardless of the reason, which cannot be definitely determined from our data, differential misclassification led to an overestimate of the risk ratio for preeclampsia when epilepsy was ascertained at delivery. This finding suggests that previous studies in women with epilepsy defined at delivery 6,7 may have overestimated the risk ratio as a result of recording bias.
For MS, 78% of women with the condition in the pre-delivery interval were also recorded as having MS at delivery when using stricter criteria. Recording did not appear to vary by Caesarean delivery, preterm delivery, and preeclampsia; and risk ratios for these outcomes were similar whether MS was identified at delivery or throughout pregnancy.
| Strengths of the study
The greatest strength of this study is the large sample size. Indeed, epilepsy and MS are relatively rare in pregnant women 7,9,18-24 and 
| Limitations of the data
Database restrictions prevented us from comparing ascertainment at delivery with a true gold standard (eg, medical records)
in pregnancy. Instead, we compared ascertainment at delivery to ascertainment before (and including) delivery using stringent definitions. While these definitions were adapted from prior literature [12] [13] [14] [15] [16] and the length of the interval was determined from comprehensive claims review (Appendix S1), some error likely still exists. To emphasize the lack of a gold standard, we calculated an estimate of sensitivity of the delivery hospitalization using the "Relative Sensitivity" and an estimate of the positive predictive value using the "Relative Predictive Value". At least one study has used a typical gold standard measure (medical records) and found that conditions such as asthma, hypertension, thyroid disorders and cardiovascular disease generally had low sensitivities (10%-58%) but high positive predictive values (86%-100%), 2 a pattern similar to MS here. Taken together, it may be reasonable to conclude that while many pre-existing conditions are under-recorded at delivery, when the conditions are recorded, often they can be confirmed by medical records 2 or more stringent definitions in pregnancy (current study).
Finally, an underlying assumption was that the misclassification of the conditions during the pre-delivery period is non-differential with regards to pregnancy outcomes. While the temporal relation of events certainly makes a direct impact of obstetric outcomes on past recordings unlikely, certain factors (eg, health care utilization) may still affect the recording during pregnancy and the risk of adverse delivery outcomes (Figure 3 ). While we cannot completely exclude the possibility of unmeasured confounders on recording, we do not believe that such covariates would exert differential effects in the two intervals.
| CON CLUS IONS
Our findings confirm that pre-existing conditions are incompletely captured on health care databases restricted to delivery hospitalization, but did not suggest that major obstetric outcomes improve the coding of these conditions. Use of cross-sectional records at delivery did not result in recording bias for most of the associations considered. However, the differential positive predictive value for epilepsy by preeclampsia suggests that epilepsy should be captured in intervals preceding the delivery hospitalization. In general, when only delivery records are available, investigators should consider whether the outcome of interest can trigger recording of the specific exposure of interest. Indeed, the potential exists and should be examined when using cross-sectional medical records.
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